共 119 条
[1]
Chiang JL(2014)Type 1 diabetes through the life span: a position statement of the American Diabetes Association Diabetes Care 37 2034-2054
[2]
Kirkman MS(1998)Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes control and complications trial JAMA 280 140-146
[3]
Laffel LMB(2003)Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study Diabetes Care 26 1374-1379
[4]
Peters AL(2008)Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study PLoS One 3 e3363-18
[5]
Purnell JQ(2015)Association between insulin resistance and risk of complications in children and adolescents with type 1 diabetes Diabetes Metab Syndr 9 14-2024
[6]
Hokanson JE(2005)Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study) Diabetes Care 28 2019-2707
[7]
Marcovina SM(2006)The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey Diabetes Care 29 2701-712
[8]
Steffes MW(2007)Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the diabetes control and complications trial Diabetes Care 30 707-113
[9]
Cleary PA(2015)BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children Eur J Endocrinol Eur Fed Endocr Soc 172 107-138
[10]
Brunzell JD(2015)Resistance Exercise in Already-Active Diabetic Individuals (READI): study rationale, design and methods for a randomized controlled trial of resistance and aerobic exercise in type 1 diabetes Contemp Clin Trials 41 129-1061